TKTL1 and cancer: In addition, the overexpression of TKTL1 in several human cancers may lead to the transformation of substrates necessary for glucose degradation (in the glycolysis pathway) (Zhang et al., 2007a; da Costa et al., 2018; Li et al., 2019).